Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Axela Biosciences is an active specialty contract research organization based in Whippany, New Jersey. Formed in late 2024 through the merger of Nanobiotec/PicoImmune and Emerther, it offers advanced preclinical bioassays, biomarker discovery services, immune cell products for research use in immunology and oncology fields, as well as CLIA-certified diagnostic assay development. The company leverages ultra-sensitive multiplex technologies to accelerate drug discovery biology and translational science for biopharma clients. Its team brings deep expertise from leading academic institutions and major pharmaceutical companies. Axela does not develop its own therapeutics but provides critical R&D support to pharma/biotech partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Axela Biosciences.